08/21/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/11/2025 6:40 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2025 6:34 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2025 6:33 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2025 6:24 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/22/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2025 1:44 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/10/2025 6:39 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/10/2025 6:44 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for QNTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
07/10/2025 6:50 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/08/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2025 9:26 AM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
06/27/2025 3:30 PM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2025 2:34 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13D/A | |
06/23/2025 10:29 AM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13D/A | |
06/17/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2025 8:53 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13D/A | |
06/13/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2025 5:15 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13D | |
06/11/2025 2:26 PM | Malone Wealth Ventures LLC (Filed by) Quantum Biopharma Ltd. (Subject) Quantum Biopharma (Subject)
| Form SCHEDULE 13G | |
06/10/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2025 6:50 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/19/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 7:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 9:01 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2025 8:34 PM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025 5:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This is my Christian duty (Ad) “This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth.
Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. Watch Jim Rickards reveal the Old Testament Wealth Code |
03/31/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025 12:53 PM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/28/2025 5:09 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025 6:00 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 9:18 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025 6:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025 3:00 PM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2025 6:31 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025 7:30 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2025 7:32 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024 8:16 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024 6:22 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024 6:31 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024 6:54 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024 7:50 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024 6:32 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 7:09 PM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 6:27 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024 6:39 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024 8:22 PM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 8:46 AM | Quantum Biopharma Ltd. (Filer) Quantum Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |